Selecting a site will automatically redirect you to the site's homepage.
Company was launched through the Center for Life Science Ventures with technology licensed through the Center for Technology Licensing.
A new material developed at Cornell could significantly improve the delivery and effectiveness of mRNA vaccines – used to fight COVID-19 – by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.
Nearly 50 Merrill Scholars gathered at the 37th annual Merrill Presidential Scholars luncheon May 20 at Willard Straight Hall.
